Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-01-12

Clinical Trial Update: Post-operative Radiotherapy in Poor Responders Ewing's Sarcoma Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating post-operative radiotherapy in poor responders with Ewing sarcoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Children's Cancer Hospital Egypt 57357 | Conditions: Ewing's Sarcoma | Phase 3 | Status: WITHDRAWN